Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trialDaniel Gaudet, S van Deventer, C Essiembre et al.|Gene Therapy|2012Cited by 399
The role of the LDL receptor in apolipoprotein B secretionJaap Twisk, Alan Attie|Journal of Clinical Investigation|2000Cited by 245
Intramuscular Administration of AAV1-Lipoprotein Lipase <sup>S447X</sup> Lowers Triglycerides in Lipoprotein Lipase–Deficient PatientsErik S.G. Stroes, Jan Albert Kuivenhoven, Melchior C. Nierman et al.|Arteriosclerosis Thrombosis and Vascular Biology|2008Cited by 208